Powered by Business Wire
July 08, 2024 11:45 AM Eastern Daylight Time

Genentech to Reintroduce Susvimo for People With Wet Age-related Macular Degeneration (AMD)

Susvimo, developed by Genentech, a member of the Roche Group, is a refillable eye implant that continuously delivers a customized formulation of ranibizumab over time. (Photo: Business Wire)
Susvimo, developed by Genentech, a member of the Roche Group, is a refillable eye implant that continuously delivers a customized formulation of ranibizumab over time. (Photo: Business Wire)
View Full Size Opens in new window

Download

Get Business Wire News on Your Website
Terms of Use   |   © 2024 Business Wire